PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
about
PTH and Vitamin D.Sustained release of parathyroid hormone via in situ cross-linking gelatin hydrogels improves the therapeutic potential of tonsil-derived mesenchymal stem cells for hypoparathyroidism.Primary hypoparathyroidism presenting as basal ganglia calcification secondary to extreme hypocalcemia.Continuous Subcutaneous Recombinant Parathyroid Hormone (1-34) Infusion in the Management of Childhood Hypoparathyroidism Associated with Malabsorption.
P2860
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@ast
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@en
type
label
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@ast
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@en
prefLabel
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@ast
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@en
P2860
P1476
PTH(1-84) replacement therapy for the treatment of hypoparathyroidism.
@en
P2093
Mishaela R Rubin
Natalie E Cusano
P2860
P356
10.1586/17446651.2015.971755
P577
2015-01-01T00:00:00Z